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Introduction
1 General information about Helicobacter pylori and its 
environment
In 1984, a few small colonies appeared on a blood agar plate after a bacterial culture of a
human stomach biopsy was forgotten over an Easter holiday in a 10% CO2 incubator at 37°C.
The bacteria forming these colonies will be known as Campylobacter pylori (Marshall et al.
1985; Marshall  and Warren 1984) .  A couple of years later,  new sequencing methods re-
defined  its  identity  as  a  new member  of  a  new family  of  the  epsilon-proteobacteria,  the
Helicobacteraceae, and it was named Helicobacter pylori (Owen 1998). The forgetful event
made  it  possible  for  the  Australian  team  to  confirm  their  ongoing  hypothesis:  gastric
pathologies are caused by a bacterial  organism in the human stomach. Once  Helicobacter
pylori was grown and identified, the team leader Dr. Barry Marshall, decided to fulfill the
Koch’s postulates and drank a liquid culture of this bacterium in hope to develop gastritis,
which he acquired after a certain time in a mild form (Marshall et al. 1985).This experiment
branded  Helicobacter  pylori as  the  cause  of  gastric  pathologies  ranging  from mild  ones
(asymptomatic gastritis) to more severe, like peptic ulceration and gastric cancer, and resulted
in awarding the Nobel Prize in Physiology or Medicine to Barry Marshall and Robin Warren
in 2005.
The next 30 years of research on this bacterium has revealed new characteristics about it and
its relationship with humans:
In the 1990’s, through epidemiological studies performed to associate the presence of the
bacteria  with the severe pathologies,  two of its  most potent  toxins where discovered;  the
Cytotoxin Associated Gene A (CagA) (Crabtree et al. 1994; Warburton et al. 1998) and the
Vacuolating Cytotoxin A (VacA) (Atherton et al. 1995; Xiang et al. 1995; Warburton et al.
1998). 
In 2000, it was discovered that CagA enters the host cell and it is modified (phosphorylated)
by certain host cell  kinases to exert  damages in cellular  function. The following research
established that CagA is injected into the cells by a Type IV secretion system, named Cag
Type IV secretion  system (Cag-T4SS)  (Odenbreit  et  al.  2000;  Backert  et  al.  2000).  The
components of this system assemble a molecular machinery capable to inject the CagA toxin
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in the host cells. It shares some similarities to the Type 4 Secretion System of Agrobacterium
tumefaciens, but it differentiates enough to drive a research spanning for over 20 years trying
to resolve its function. The main reason for the research on the CagA toxin is its association
with high levels of immune cell infiltration in the stomach mucosa of patients colonized by
H. pylori strains  causing  chronic  inflammation.  This  phenotype was  later  explained  as  a
consequence  of  the  increased  production  of  chemokines  by epithelial  cells  from patients
infected with bacteria containing the Cag-T4SS and the CagA toxin  (Singer and Sansonetti
2004; Crabtree et al. 1994; W Fischer et al. 2001; Stein, Rappuoli, and Covacci 2000). 
Since its discovery most of the research has concentrated on the ability of H. pylori to cause
disease.  Several  publications  highlight  the  amount  of  damage  caused  by  it  and  how  to
eliminate it. The medical community searched to establish uniform diagnostic parameters and
treatment procedures with the only purpose to battle this microbe. These efforts resulted in a
standard description  of the  chain of events  and changes  in  the gastric  mucosa leading to
gastric cancer (Correa and Piazuelo 2012) (Figure 1). Additionally, eradication programs were
placed  using  different  combinations  of  antibiotics  with  recommendation  to  all  medical
community to eradicate upon discovery. 
Figure 1. Gastric pathologies evolution related to the presence of H. pylori.
From Correa & Piazuelo J Dig Dis. 2012;13:2–9
However, two key questions remained open: How is H. pylori transmitted and what or where
is the natural host / reservoir of this bacterium? Studies addressing these questions are plenty.
There have been assumptions that  water,  flies and food are sources of contamination and
responsible for transmission (Vaira et al. 1998; Engstrand 2001; Linz et al. 2013). While the
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way of transmission is still a subject of debate, it has been now accepted that H. pylori lives
only in the human stomach; and the fact that  H. pylori is only evolving with humans was
confirmed during studies analyzing sequences from H. pylori strains isolated from around the
world. The data showed a correlation between variations of specific H. pylori genes and the
actual data from human migrations, which depicts a co-evolution between humans and  H.
pylori and underlines the robust relationship between them  (Falush et al. 2003; Linz et al.
2007).
Since its discovery, the medical community agreed that H. pylori should be eliminated upon
diagnosis, and a cascade of events affecting those who were treated started to unveil a visible
trend in developed countries: A higher incidence of esophagus related pathologies. One of the
first concrete reports about possible consequences of the eradication of H. pylori appeared in
the beginning of the 21st century, when the group of Martin Blaser observed lower risk of
Barrett’s Esophagus in patients infected with H. pylori (Vaezi et al. 2000) and the group of
Farin Kamangar performed a meta-analysis revealing that the lack of H. pylori correlates with
an increased risk of developing Barret’s esophagus, which can develop in esophagus cancer
(Islami and Kamangar 2008; Fassan et al. 2009).
Subsequent  studies  have  shown  that  lack  of  H.  pylori increases  the  chances  of  asthma
development in children and young adults (Reibman et al. 2008). This apparently protective
effect of  H. pylori for asthma was corroborated in experimental animal studies using mice
(Arnold et al. 2011). Other diseases hallmarked by failure of an adequate immune response
can  also  be  linked  to  the  presence  of  H.  pylori,  as  in  the  case  of  Multiple  Sclerosis,
Inflammatory Bowel Syndrome (IBS) and Crohn’s disease  (Li et  al.  2007; Gavalas et  al.
2015; Halme et al. 1996).
At the moment, 30 years of research in Helicobacter pylori, together with a new perspective
on the relevance of the human microbiota in health and disease, might change the view we
have of Helicobacter pylori from human pathogen to human symbiotic organism.
2 Objective and purpose of this professorial dissertation
Research around microorganisms and their relevance in health and disease has increased since
genomic  identification  has  overcome  the  challenges  of  the  need  of  cultivation  for  their
identification. At the same time, the scientific and medical communities are accepting that
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 6 of 34
Accumulative Professorial Dissertation
microbes and their interrelationship on the human surfaces, like the gut, can alter the function
of organs, including the brain (Rhee, Pothoulakis, and Mayer 2009). 
As such, and because of the studies I have performed in the last years on  H. pylori, I am
inclined  to  consider  Helicobacter  pylori not  a  pathogen.  I  cannot  deny  that  it  possesses
mechanisms and molecules that can trigger severe damage on the gastric tissue, but let us not
forget that “For a fight, two are necessary”, and part of this damage is caused by the host´s
immune reaction.  H. pylori can defend itself against an immune response; it has the means
and  no  real  known  competition  in  its  environment.  By  investigating  the  situations  or
conditions in which the toxins are causing damage, we might be able to find a way to co-exist
for other thousands of years with it as we have done until now.
2.1 Objectives
 Studies on cellular parameters needed for the deleterious effects of CagA and VacA on
host cells.
 Establishment of a reliable quantification of the amount of CagA injected into the host
cells through western blot analysis.
 Ecology of  Helicobacter  pylori:  what  happens to  their  toxicity  when they have to
share the same host?
2.2 Studies  on  cellular  parameters  needed  for  the  deleterious
effects of CagA and VacA on host cells
Publications: Sewald et al 2011, Jiménez-Soto et al 2009, Kaplan-Türköz B Jiménez-Soto et al 2012,
Pham KT et al 2012
Toxins  need  to  reach  their  target  in  order  to  exert  their  deleterious  effect  on  cells.
Helicobacter pylori uses different mechanisms to deliver their VacA and CagA toxins. Both
toxins are transported across the two-membrane system of the bacterium (inner and outer
membrane) thanks to molecular machines termed secretion systems. While VacA is exported
to the outer membrane and released to the supernatant through a Type V secretion system
(Wolfgang  Fischer  et  al.  2001),  CagA  is  injected  directly  into  the  host  cell  through  a
machinery  denominated  the  Cag  Type  IV  Secretion  system (Cag  T4SS)(Odenbreit  et  al.
2000). 
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A  very  important  function  of  VacA  is  its  capacity  to  regulate  the  immune  response.  It
achieves  it  by blocking the release  of  the  cytokine  interleukin-2 (IL-2).  Part  of a normal
response  from  T-cells  includes  their  clonal  expansion  and  this  is  signaled  by  the  IL-2.
Therefore, VacA is able to inhibit the proliferation of T-cells hindering them to adequately
respond to a  H. pylori infection  (Gebert  et  al.  2003).  Similar  activity  is  presented by the
gamma glutamyl transpeptidase of H. pylori (Oertli et al. 2013) Since VacA is released into
the environment, it needs to be actively taken up by T-cells upon contact with its receptor, the
Integrin Beta 2 (ITGB2) (Sewald et al. 2008). However, binding is not all what is needed and
the timing has to be adequate. Therefore, cellular events activating ITGB2 by serine/threonine
phosphorylation  through  cellular  PKCs  set  in  motion  the  uptake  of  the  VacA  toxin  by
endocytosis, which affects the IL-2 production (Sewald, Jimenez-Soto, and Haas 2011). Some
details on the internalization steps are still unknown: does the clustering of ITGB2 facilitate
the insertion of the toxin into the membrane and its uptake or is it during the normal recycling
of activated ITGB2 by the T-cells that the toxin enters the endocytic system and inserts itself
into the membrane? Independently of the mechanism, the capacity of VacA to reach its target
cells  without direct contact makes it  ideal for deployment as a long-range effector on the
immune response to H. pylori.
While VacA may act on remote areas of the gastric mucosa, CagA reaches its target only
when bacteria achieve close contact to the target cell. Since it is directly injected into the host
cell, the machinery requires a docking place or cellular receptors. One of them is the cellular
integral membrane protein Integrin beta 1 (ITGB1) which interacts with four components of
the T4SS machinery: CagL (Kwok et al, 2007), CagA, CagI and CagY (Jimenez-Soto et al.
2009). 
We have further looked at  the mechanism of how these proteins are able to interact with
ITGB1. In collaboration with the excellent crystallography team of Laurent Terradot in Lyon
(France), the crystal structure of the N-terminal region of CagA is now known and we have
located the region of CagA that interacts with ITGB1 within the amino acids 310 and 450 of
the protein. A recombinant oligopeptide containing this region competes with the natural Cag
T4SS reducing the amount of CagA translocated into the host cells  (Kaplan-Turkoz et  al.
2012).
Additionally, our studies on two of the proteins interacting with ITGB1, CagI and CagL show
that both proteins interact with each other. As a consequence, any mutation in one of them
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leads  to  the  instability  of  the  other.  These  results  highlight  their  importance  in  the
functionality of the Cag T4SS and its associated functions (Pham et al. 2012).
Recent  work  in  our  team has  discovered  that  Outer  Membrane  Proteins,  specifically  the
HopQ, are necessary for the functionality of the Cag T4SS and that other receptors on the cell
might be used for the translocation in the cell  (Belogolova et al. 2013; Königer et al. 2016;
Javaheri et al. 2016). Ongoing work will bring further insights in the mechanisms underlying
the efficient translocation of CagA in the host cell.
2.3 Establishment  of  a  reliable  quantification  of  the  amount  of
CagA injected into the host cells through western blot analysis
Publications: Jiménez-Soto et al 2012, Zeitler et al 2016, Jiménez-Soto et al 2016.
Helicobacter pylori is considered a fastidious microorganism which has to be grown on rich
media complemented with serum. Independently of the serum’s origin (human, ovine, bovine
or  equine),  its  animal  origin  causes  variability  between  production  lots  and  companies.
Additionally,  the ITGB1 is able to interact with serum proteins making the growth of the
bacterium  on  serum-complemented  media  a  variability  factor  for  our  studies  on  CagA
translocation (see above). H. pylori is able to extract cholesterol from eukaryotic cells and use
it for growth thanks to its cholesterol-trans-glucosidase protein (Ctg)  (Wunder et al. 2006).
We  therefore  developed  new  solid  and  liquid  media  with  cholesterol  and  fatty  acid
complementation instead of serum. The validation of the new media showed that most  H.
pylori strains responded well to the cholesterol supplement and the lack of serum proteins
strongly facilitated extraction of secreted bacterial proteins for further studies (Jimenez-Soto
et al. 2012). 
The effect of cholesterol complemented media on CagA translocation showed us the need to
evaluate  CagA translocation  in  a  quantitative  form. Until  that  moment,  analysis  of CagA
translocation has been restricted to a yes/no question by evaluating the presence or absence of
tyrosine phosphorylated CagA in an infection, since effective CagA translocation causes that
CagA is phosphorylated by the host cell kinases Src and Abl on the EPIYA motifs (Mueller et
al.  2012;  Stein,  Rappuoli,  and  Covacci  2000;  Poppe  et  al.  2007).  Recent  methods  for
quantification  have  been  developed  in  our  team  using  a  beta-lactamase  fused  to  the  N-
terminal domain of CagA (Schindele et al. 2016). Although extremely helpful for studies with
high throughput, because of the use of fluorescence as readout, it depends on the enzymatic
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capacity of the fused enzyme, which requires a certain amount to reach detection and, at the
same time, it can reach a saturation point in different times of an experiment, depending on
the  experimental  conditions  and  cellular  fitness.  Therefore  we  chose  to  use  the
phosphorylation signals from the standardized detection method to achieve a quantification of
CagA translocation.
Traditional methods used in cell biology studies for semi-quantitative analysis of western blot
signals assume that housekeeping protein levels remain constant. Therefore, the signal levels
of detection of the protein to be tested are normalized to the signals of the housekeeping
proteins (HKP). This quantification system presents conflicts in infection biology, since the
treatment  with an organism that alters  cell  processes can change the levels  of HKP. Any
changes in HKP expression abolishes the purpose of this proteins as normalization factor. To
solve  this  problem,  we adapted  the  use  of  the  Stainfree  system for  the  semi-quantitative
evaluation of levels of CagA phosphorylation (Gurtler et al. 2013). The new protocol does not
require  the use of HKP as normalization factor.  Instead it  uses the signals of tryptophan-
containing proteins that do not overlap with the signals of the bacteria. The validation of this
method  showed  us  a  more  stable  quantification  of  densitometry  signals  and  opened  the
possibility to evaluate several aspects of infection (Zeitler et al. 2016).
The previously described procedure, together with the development of a method for removal
of  external  bacteria  after  infection,  allowed  us  for  the  first  time  to  determine  the  actual
amount of CagA toxin injected in the host cells during the course of an  in vitro infection.
Only  1.5% of  the  whole  CagA present  in  infection  assays  is  injected  into  the  host  cells
(Jimenez-Soto and Haas 2016). This came as a surprise considering that CagA is the 4th most
produced protein by the bacteria, requiring a high amount of resources (Jungblut et al. 2000).
These results are contradictory: very low amounts of the produced CagA are injected in the
host cells and are still able to alter the cells. The synthesis of a 140 - 170 kDa protein requires
many  resources  from the  bacteria,  which  opens  the  possibility  to  the  existence  of  other
functions for CagA that do not include translocation in the host cell. Future studies will be
aimed  to  determine  if  the  CagA found  outside  of  the  bacterium plays  an  active  role  in
infection.
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2.3.1 Ecology of Helicobacter pylori: what happens to their toxicity
when different H. pylori have to share the same host?
Publications: Jiménez-Soto et al 2013, Zeitler et al 2017, Rojas-Rengifo et al 2015, Rojas-Rengifo et al
(manuscript in preparation).
In nature many kinds of Helicobacter pylori strains exist. Based on the presence of CagA and
VacA and their variants, the strains were classified as Type I and Type II (Xiang et al. 1995).
While more classifications were proposed, at the moment it has been agreed that all strains
containing the cagA gene are Type I (cagA +) while all lacking the gene are Type II (cagA -)
strains.
2.3.1.1Data from in vitro studies
Infection of humans can include several different strains of bacteria. As with any living being,
there might  be competition for resources,  like for iron. At the same time CagA has been
implied in the iron homeostasis on in vitro assays (Tan et al. 2011). For CagA to be injected
in  the host  cells,  it  requires  cellular  receptors,  which  makes feasible  that,  under  multiple
infections,  bacteria  will  compete  for  them  in  order  to  inject  CagA.  Taking  this  in
consideration, we performed experiments with the purpose to find out if certain Type I strains
are more effective in translocation during co- and pre-infections (See Figure 2 for description
of experimental setup). We found that regardless of the Type I strains used, if both were
added simultaneously (co-infection), both strains were not able to inject the CagA as efficient
as when they were alone. But what happens when one of the strains has 60 min advantage? In
this case the second strain was unable to inject its CagA (reduction up to 90%). Is it possible
that the competition was for the receptor? If yes an isotype mutant lacking the T4SS will have
no effect on CagA translocation in both setups. Our data contradicted this hypothesis: Strains
without  Cag  T4SS  caused  exactly  the  same  effect.  After  verifying  different  aspects  like
binding capacity of both strains, minimum amount of bacteria required for the effect, transfer
of strains from one well to another to rule out effect from one bacteria to the other, etc.; we
found that: i) the reduction is caused as a response of the cell to its contact with the bacteria,
ii) the triggering agent on bacteria is of protein nature, iii) binding of the secondary strain is
not affected by the first one, iv) the reduced amount of CagA phosphorylated is not an effect
on diminished host kinase activity, v) outer membrane proteins HopQ, HopI, AlpB and BabA
play  a  role  in  the  triggering  mechanism in  the  cell,  and  vi)  very  low levels  of  bacteria
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(Multiplicity Of Infection MOI 5) are able to trigger a measurable response from the cell
(Jimenez-Soto et al. 2013).
Figure 2 Experimental setup for the co- and pre-infection experiments.
Cells were synchronized and infected simultaneously (co-infection) or with time delays (pre-infections) with two different H.
pylori strains (Strain A and Strain B in graphic). For each time point where the translocation-capable strain (Strain B) was
added, a control infection was done in order to evaluate the normal capacity of the bacteria to translocate CagA in the assay.
The amount of translocated CagA by the control infection determines the control value for the semi-quantitative analysis of
translocation.
Based on the reduction of CagA translocation, we expected that the effect of resistance to
CagA translocation should reduce the damage in the cytoskeleton associated with a CagA
phosphorylation. This damage causes a deformation of the cells known as the “Hummingbird”
phenotype, characterized by elongation of the cells and loss of contact points deforming the
cell  in  a  form reminding  a  hummingbird  in  flight.  This  hypothesis  was verified,  and the
deformation of the cells was strongly reduced and sometimes none existent, even when the
values of CagA reduction were only 50%, which could mean that the AGS cells used in our
experiments  have  a  certain  threshold  for  the  amount  of  CagA  that  starts  to  affect  the
cytoskeleton and the adhesion to the surface of the plates (data not shown). We also observed
that co- and pre-infection experiments reduced the level of IL-8 secretion usually triggered by
a functional Cag T4SS, which will hypothetically reduce the quantity of neutrophils recruited
to the areas where  H. pylori is interacting with the host cells. By having less inflammatory
cytokines, less damage will be caused by the immune response in the gastric tissue, which
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will ensure the survival of the host and the bacterium at the end of the day. The reduction of
IL-8 indicates as well that the whole mechanism for CagA translocation has been affected, not
only the translocation of CagA, which plays no direct role in the levels of IL-8 induced by H.
pylori (Sokolova et al. 2013)
All  these  data  were  obtained  from  in  vitro infections  with  AGS  cells,  a  gastric
adenocarcinoma standard cell line for CagA translocation assays. These cells have epithelia-
like characteristics; however, CagA can be translocated as well in immune cells (Odenbreit et
al. 2001). Therefore, we performed the same experiments in a human macrophage-like cell
line,  THP-1,  and  in  primary  human  blood  leukocytes.  In  both  cases,  multiple  infections
reduced the amount of translocated CagA (Figure 3). 
Figure 3. CagA translocation blocking effect in immune cells
In  all  cell  types  the  presence  of  two  infecting  strains  reduced  the  amount  of  CagA  translocated  (Control  CagA
phosphorylation levels are represented by the dotted line (Value 1).  However, while in AGS cells (A) there is a strong
difference between the co- and pre-infection, in primary leucocytes (B) is no difference observable; and in THP-1 cells, a
macrophage-like leukemia cells line, although significant, the difference is strongly reduced compared to that observable in
AGS cells.
The differences between co- and pre-infection could be caused by two different responses of
the cell or by a progressive and accumulative cellular process. To determine which of both
possibilities  is  the  most  plausible,  we  performed  a  time-lapse  evaluation  of  CagA
translocation and additionally IL-8 secretion (Figure 4). As seen here, the most significant
effect on CagA translocation during pre-infection occurred suddenly after 50 minutes pre-
infection. Early time points are able to reduce, but show no real progressive pattern in the
diminished  amount  of  CagA  translocation.  On  the  contrary,  they  are  statistically
distinguishable from the strong pre-infecting effect after 50 minutes, for which we conclude
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that both phenotypes are independent events, for which the cell most probable uses different
cellular processes to resist CagA translocation.
Figure 4. Time lapse evaluation of CagA translocation and IL-8 production during co- and pre-infection experiments.
For CagA translocation (A), the co-infection (considered time 0) effect is distinguishable from the strong pre-infection event
only after 50 min of pre-infection. In case of IL-8 (B), already after 15 min the pre-infection (blue line) is distinguishable
from the control infection (red line) concerning IL-8 levels, and this is constant up to 60 minutes pre-infection.
Once established that resistance to CagA translocation is a common response of the cells to
multiple infections, we asked ourselves if combinations if different  H. pylori will cause the
same response.  Experiments  with different  combinations  of Type I  strains and Cag T4SS
deficient  strains,  one mutant  (P12ΔT4SSs) and two type II  wild strains  (X47 and Tx30a)
showed that although the general effect was there (Figure 5A), some type I strains responded
differently to the pre-infecting strains (Figure 5 (5B to 5C). As we compared these data to the
effect on IL-8 secretion Cag T4SS dependent, we observed that the effect on IL-8 induction
was only statistically significant in two of the five (5) strains tested (data not shown). As a
conclusion, although multiple infections can trigger resistance to CagA translocation and its
toxic  effects,  the amount  of  IL-8 produced by the cells  are  not  always dependent  on the
combination of strains used. 
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Figure  5.  Resistance  to  CagA translocation  by  AGS cells  in  presence  of  different  wild  type  multiple  infections
combinations.
Overall  (A),  co- and pre-infection will always trigger resistance to the translocation of CagA, each combination of pre-
infecting strains (see details for each of the strains in publication attached) with translocating strains (P12, P145, G27, P217
and 26995, A-F) caused different levels of blocking. More important, there is a tendency for the wild type type II strains
(CagA negative) to block less than the isotype mutant of a type I strain (P12ΔT4SSs).
The results  obtained with  multiple  infections  in  vitro can have  great  implications  for  the
clinical treatment of H. pylori if they could be translated to the human infection/colonization.
The distinctive feature of pathologic  H. pylori infection is the high level of infiltration of
neutrophils in the stomach mucosa, producing gastritis, which, if it turns chronic, may lead to
atrophic gastritis, intestinal metaplasia and finally gastric cancer. A few previous publications
have already observed less damage in stomach tissue when type I and type II  strains are
present  (Figura et al. 1998; Secka et al. 2011), but none of the studies have evaluated two
critical  aspects:  How often does a multiple infection with type I and type II strains takes
place? And how does this correlate with the gastric pathology? Therefore, I have started a
collaboration with the microbiological laboratory in the Universidad de los Andes and with
the gastroenterological department of the hospital Fundacion Santafé de Bogotá to evaluate
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both aspects and determine if the  in vitro effect of multiple infection is relevant in clinical
conditions.
2.3.1.2Clinical Studies
2.3.1.2.1.1How often is a mixed infection present in Colombian patients?
Although some early studies confirm that patients can have multiple H. pylori strains in their
stomach, to date no study has ever looked for the proportions of type I and type II in them.
For this purpose we developed a quick method that allows us to screen 100 isolates per patient
to classify them as type I (CagA+) or type II (CagA - ) (Rojas-Rengifo et al. 2015). Although
Colony Lift Immunoassays had been already reported for proteins found on the surface of
bacteria, none where designed for proteins inside the bacteria, as is the case for CagA. While
some bacteria  have CagA on their  surface,  the  highest  amount  is  found inside.  We were
successful in establishing the immunoassay, which allowed us to perform the screening of
patient isolates, 50 colonies from antrum and 50 from corpus region of the stomach, in a fast
and economic way (Rojas-Rengifo et al. 2015).
Our first data revealed that only 26% of the studied population had H. pylori colonization, in
contrast with reported 69% (Urease Breath Test, UBT) in 1996, 96.3% (Seropositive) in 2000
and 69,1% (histology) in 2003  (Goodman et al.  1996; Bravo et al.  2000, 2003). The low
prevalence in our population is in accordance to another study performed in another capital
city (Medellin) of Colombia, which revealed a prevalence of 36% (Correa G. et al. 2016).
The results from 92 positive samples show that H. pylori colonization with type I and type II
is normal in the Colombian population evaluated, with most of the patients presenting mixed
infections (57,3%), 26% presenting only type I strains and 16% type II strains. Since it is the
first  time  that  this  level  of  detail  on  the  types  of  H. pylori present  in  patients  has  been
evaluated, it was interesting to realize that strains in patients with mixed population (Type I
and Type II) did not present any tropism for the areas of the stomach evaluated (antrum and
corpus).  Additionally,  during  biopsy  extraction  procedures,  it  was  noted  by  the
gastroenterology team that the urease test performed routinely in the hospital directly on the
biopsies, showed differences in certain patients by showing urease positive or negative results
depending of the origin of the biopsy (antrum or corpus, personal communication with Dr.
Belen Mendoza de Molano). As a consequence, the gastroenterological team in the hospital
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has adapted the testing procedures in order to improve the diagnosis as a clinical service to the
patients, by taking antrum and corpus biopsies for a reliable urease test. 
2.3.1.2.1.2Is  there  a  correlation  between  Helicobacter  pylori  infections  and  pre-
cancerous lesions in the population evaluated?
Pelayo Correa has proposed a cascade of events that occur upon infection with H. pylori (see
Figure 1), where atrophic gastritis (lack of gastric glands in tissue) is the first change observed
in the tissue leading towards cancer. This sequence has been accepted by most of the medical
community.
Therefore, we compared the presence of atrophic gastritis and intestinal metaplasia changes,
evaluated by the pathology department in the Fundación Santafé de Bogotá, with data from
the  microbiological  analysis.  To our  surprise,  there  was no relation  between any of  both
pathologies  and  the  H.  pylori status  (OR 0.87).  From 400  patients,  only  age  showed  to
correlate with the presence of both pathologies. This contradicts all what is known about both
pathologies and the Colombian population, which is considered to be one of the countries
with the highest incidence of gastric cancer (Kudo et al. 2005) and several populations from
the southwest coast and mountain regions have been studied previously showing a correlation
of  H. pylori and gastric cancer  (Goodman et al. 1996; Torres et al. 2013). However, other
factors, like social-economic status have to be considered before comparing the data from the
population we analyzed and those previously reported, since the population admitted to the
hospital Fundación Santafe de Bogota, attends the socio-economical classes 5 and 6, which
represent the higher middle class and high class of the Colombian population.
The data obtained in our study suggests that  H. pylori is not the cause of severe forms of
gastric tissue changes and that other factors, e.g. environmental or social influences might be
important in the development of pre-cancerous gastric lesions in the population analyzed.
2.3.1.2.1.3Does the level of type I and type II strains in a stomach affect the level of
inflammation in patients?
Although our  results  contradict  the published relationship  of  H. pylori and pre-cancerous
lesions,  we decided to evaluate  the effect of a mixed infection for the level  of neutrophil
infiltration in tissue.
Considering  that  neutrophil  infiltration  in  the  tissue  causes  inflammation,  and  chronic
inflammation can lead to carcinogenesis (Fu et al. 2016), we analyzed the levels of neutrophil
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infiltration  (neutrophil  activity)  in  the  mucosa  of  all  patients  with  mixed  infections,  to
compare if the percentage of type I vs type II strains in each patient correlates with variations
in neutrophil infiltration. We observed no correlation between the percentages of Type I and
Type II strains with the level of neutrophils in the tissue analyzed (Figure 6).
Figure 6. Effect of proportions of type I and type II strains of H. pylori in tissue levels of neutrophil infiltration.
Violin plots showing the distribution in percentage of type I strains in mixed infected patients (Y-axis) vs the levels of
neutrophil infiltration in tissue (X-axis), ranging from no neutrophil detection (0) in mucosa to high levels of neutrophil
detection in the upper mucosa (3). The grading was done in accordance to international standards for diagnostic (Sydney-
System)
2.3.1.2.1.4Effect of multiple infections in adaptation to cytokine induction
From each  patient,  the  strains  evaluated  in  the  colony blot  assay  were  stored  for  further
analysis. We selected Type I strains from patients with mixed infections and compared them
to the Type I strains from patients presenting only Type I strain infection in their capacity to
induce IL-8, an important cytokine in the recruitment of neutrophils to the infected tissue. Our
data revealed that the type I strains from mixed infection patients induced less IL-8 than those
from type I strains only (Figure 7). This could indicate a selective pressure to develop less
gastritis in those patients presenting Type I and Type II strains compared to those with only
Type I strains. 
Taking advantage of the advances made in recent years on genome sequencing, I am planning
to further analyse the genome of these strains and get an idea of the genetic adaptations that
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have been taking place in the strains Type I from mixed patients in order to reduce their
impact on the immune response of cells. 
Figure 7. Effect of strain origin in IL-8 induction. 
Type I strains from mixed strains-infected patients induce less IL8 production than Type I strains from Type I strain-infected
patients. Statistical analysis using a Kruskal-Wallis chi-squared = 6.3712, df = 1, p-value = 0.0116
2.3.1.2.1.5Do  strain  combinations  from  patients  show  the  same  variability  as
observed with the lab strains?
We have observed that different combinations of Type I and Type II strains cause variations
in the level of blocking CagA translocation.  But is this  the same in the host? In order to
answer this question, we used the isolated strains from patients with mixed infections, and we
tested their capacity of CagA translocation and IL-8 induction during co- and pre-infections
in vitro to evaluate their capacity to block the CagA translocation in AGS cells. At the same
time,  we wish to  observe  if  the  histological  data  (neutrophil  activation  and presence and
absence of atrophic gastritis) correlate with their  in vitro behavior. The data confirmed that
different combinations of strains cause different effects in CagA translocation (Figure 8) as it
was observed previously with the laboratory strains (see above) and that their differences vary
depending  on  the  combination  of  the  strains.  Remarkable  was  the  data  obtained  for  co-
infections with strains from patient 163, which reveal a potentiation of the amount of CagA
translocation, in some cases to a double amount of what the single infection control achieved.
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This shows that not only can the mixture of strains cause a reduction of toxin in the cells, but
as well, certain combinations can promote the toxicity of the bacteria.
Sadly, due to the low number of mixed colonies that survived the shipping from Colombia in
order to do the evaluation in Germany, we cannot reach any conclusion regarding the strains’
behavior in vitro in relation with the histological data obtained. Further efforts will be made in
order to develop a safe passage and survival of strains during transport, and therefore increase
the amount of strain combinations evaluated in in vitro assays.
Figure 8. Blocking of CagA translocation in co and pre-infection assays by type II strains with their corresponding
type I strains from mixed infected patients.
Type I and Type II strains from five (5) patients (Patient numbers 101,163, 205, 219 and 230, X axis) with mixed infections
were used for co- and pre-infection experiments (red and blue boxes, respectively) and the amount of CagA translocated
evaluated in each condition relative to the infection controls (Y axis, fold normalized to control infection (single infection
with CagA positive strain)) that represent a value of 1 and it is represented by the dotted line.
3 Concluding remarks and Outlook of the research
Research on Helicobacter pylori as a pathogen has shed light on the pathogenesis mechanisms
that this bacterium has developed in order to survive in the human stomach. The last 30 years
have brought light especially to the way the major toxins CagA and VacA are able to modify
their stomach environment and control the immune response of the host. At the same time, the
insight we have gained through this research has revealed a novel aspect of its relationship
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with humans: H. pylori has been part of the human stomach since before humans migrated out
from Africa (Linz et al. 2007). 
We cannot deny that the use of toxins by H. pylori can be deleterious to the gastric tissue. Our
studies  performed  with  the  purpose  of  learning  more  about  the  molecular  and  cellular
requirements to cause disease are important in order to diminish their effect. However, our
data on the resistance to CagA toxin effects by co- and pre-infections have revealed that the
ecology of H. pylori can have an important effect on the toxicity of this oncogenic protein and
therefore in their relationship with its host.
At the same time, considering that recent research shows that exposure to H. pylori reduces
the incidence  of diseases related to imbalanced immune responses,  we should rethink the
eradication policy applied upon its discovery on gastric tissue and consider other possibilities
to reduce the capacity of the bacteria to trigger damage in the human stomach, and this can be
achieved through basic research on its biology and its interaction with other microorganisms
present in the host, independent if they are transient or resident flora. All can have an impact
on the behavior of H. pylori 
For now, if our  in vitro data on multiple  H. pylori strains infecting the same host can be
confirmed in human patients, we would not only have found an explanation for disagreements
previously  published  about  the  correlation  of  CagA  presence  and  disease,  but  we  could
consider the use of Type II strains as a method to bring back the balance to the ecosystem in
the stomach and to reduce the immune response causing chronic inflammation.  This idea
should be approached carefully. Our data has revealed that although most of the  H. pylori
strain  combinations  reduced  the  effect  of  CagA toxin  and  the  levels  of  proinflammatory
cytokine IL-8 induced  in vitro, it shows as well that a personalized evaluation for the best
combination of bacteria will be necessary, in order to obtain the best results in a therapy of
gastritis using inoculation of adequate H. pylori strains. 
It is my wish to follow a field of research that combines recent discoveries concerning the
effect of microbiota and disease and our knowledge of H. pylori to re-evaluate the treatment
of gastric diseases related to H. pylori colonization. And in order to do so, we have to start to
consider  H. pylori not as a pathogen, but as commensal bacteria, and to treat the associated
gastric diseases as a consequence of dysbiosis.
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 21 of 34
Accumulative Professorial Dissertation
Table of Figures
Figure 1. Gastric pathologies evolution related to the presence of H. pylori.............................4
Figure 2 Experimental setup for the co- and pre-infection experiments....................................9
Figure 3. Blocking effect in immune cells..................................................................................9
Figure 4. Time lapse evaluation of CagA translocation and IL-8 production during co- and
pre-infection experiments.........................................................................................................10
Figure 5. Resistance to CagA translocation by AGS cells in presence of different wild type
multiple infections combinations..............................................................................................11
Figure 6. Effect of proportions of type I and type II strains of  H. pylori  in tissue levels of
neutrophil infiltration................................................................................................................13
Figure 7. Effect of strain origin in IL-8 induction....................................................................14
Figure 8. Blocking of CagA translocation in co and pre-infection assays by type II strains with
their corresponding type I strains from mixed infected patients...............................................14
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 22 of 34
Accumulative Professorial Dissertation
Acknowledgements
From a very early age, since visiting my grandparents farm, I developed an immense love for
nature and a strong curiosity for its processes. As a result, I possess a strong appreciation for
life and the interactions of all living beings. As microbiologist I decided to concentrate in the
interactions of VERY small living beings. I have learned so much from them and their role in
nature  in  my years  of  research,  and an  integral  part  of  my research  I  have  been able  to
communicate further all the marvelous tricks and details my work has taught me about cells,
bacteria and viruses. But all could not have been possible without very important people in
my life. The first one I want to thank is my husband. He is my strongest sponsor and he has
been my greatest  support during my life as scientist.  But this  career could not have been
possible without the support and open mindedness of Rainer Haas, my mentor and complice
in curiosity about Helicobacter pylori. He has supported my unconventional view of life and
allowed me to follow many ideas. Many of them have not made it to this document, as it is
normal  in scientific  research,  but all  of them have taught  me more about myself  and the
people around me. 
I want to thank Walther Mothes for opening me the door to research and the marvelous world
of cell biology from the microbial view. Here I learned that in order to get to know the cells, I
have to follow the steps of the experts: Bacteria and Viruses.
One of the side-effects or research in an university, is the work with students. I have enjoyed
this every minute, even when I thought I had not time for it, but there is no better feeling as
the one I experience every time I tell my students the details of microscopic life and I see in
their eyes the shine that comes with understanding and the thousand questions coming behind.
I want to thank all  of them: My students Heide Kevill,  Mary Haas, Sarah Jacoby, Sabine
Clausen, Annika Sprenger, Anna F. Zeitler, Kristina Petri, Katrin H. Gerrer and Ham Duyen
Nguyen. The graduate students that I have helped to supervise (and survive their PhD Thesis):
Utkarsh Jain, Claudia Ertl, Diana F. Rojas-Rengifo and Cindy P. Ulloa. In addition, I would
like  to  thank  each  of  the  medical  students  that  have  laughed  and  enjoyed  with  me  the
discovery of their microbial flora in medical microbiology course. 
I have had the chance to exchange my ideas and discuss their plausibility with very good
friends and brilliant minds. I want to thank them for their patience and their time to discuss
them. There are Xaver Sewald, Evelyn Weiss, Simone Bergmann, Laurent Terradot, Bettina
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 23 of 34
Accumulative Professorial Dissertation
Gebert, and Hanna-Mari Baldauf. Although we cannot get together as oft as we would like, I
appreciate every word we are able to exchange. Even a “Guten Morgen”.
I hope I have not missed anybody, but if I did: Thanks for all the fish!
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 24 of 34
Accumulative Professorial Dissertation
References
Arnold,  I  C,  N Dehzad,  S  Reuter,  H  Martin,  B Becher,  C  Taube,  and  A Muller.  2011.
“Helicobacter pylori Infection Prevents Allergic Asthma in Mouse Models through the
Induction of Regulatory T Cells.” J Clin Invest 121 (8): 3088–93. doi:10.1172/jci45041.
Atherton,  J C, P Cao, R M Peek Jr.,  M K Tummuru, M J Blaser, and T L Cover. 1995.
“Mosaicism in  Vacuolating  Cytotoxin  Alleles  of  Helicobacter  pylori.  Association  of
Specific vacA Types with Cytotoxin Production and Peptic Ulceration.” J Biol Chem 270
(30): 17771–77. http://www.ncbi.nlm.nih.gov/pubmed/7629077.
Backert,  S,  E  Ziska,  V  Brinkmann,  U  Zimny-Arndt,  A  Fauconnier,  P  R  Jungblut,  M
Naumann, and T F Meyer. 2000. “Translocation of the Helicobacter pylori CagA Protein
in Gastric Epithelial  Cells by a Type IV Secretion Apparatus.”  Cell Microbiol 2 (2):
155–64.
Belogolova,  E, B Bauer, M Pompaiah, H Asakura, V Brinkman, C Ertl,  S Bartfeld, et al.
2013. “Helicobacter pylori Outer Membrane Protein HopQ Identified as a Novel T4SS-
Associated Virulence Factor.” Cell Microbiol. doi:10.1111/cmi.12158.
Bravo, Luis Eduardo, Armando Cortés Buelvas, Edwin Carrascal, Pelayo Correa, and Nora
Ordóñez. 2000. “Seroprevalencia de Anticuerpos Anti-Helicobacter pylori En Donantes
de  Sangre de Regiones  Colombianas  Con Diferencias  En La Mortalidad  Por  Cáncer
Gástrico.”  Colombia  Médica 31  (3):  122–30.
http://www.redalyc.org/html/283/28331304/.
Bravo,  Luis Eduardo,  Armando Cortés Buelvas,  Edwin Carrascal,  Roberto Jaramillo,  Luz
Stella  García,  Paco  Eduardo  Bravo,  Aníbal  Badel,  and  Pablo  Andrés  Bravo.  2003.
“Helicobacter  pylori:  Patología  Y  Prevalencia  En  Biopsias  Gástricas  En  Colombia.”
Colombia Médica 34 (3): 124–31. http://www.redalyc.org/html/283/28334303/.
Correa, P, and M B Piazuelo. 2012. “The Gastric Precancerous Cascade.” J Dig Dis 13 (1): 2–
9. doi:10.1111/j.1751-2980.2011.00550.x.
Correa G., Simón, Andres Felipe Cardona A., Tomas Correa G., Luis Alfonso Correa L.,
Héctor  Iván García  G.,  and Santiago  Estrada  M. 2016.  “Prevalence  of  Helicobacter
pylori and Histopathological Features in Gastric Biopsies from Patients with Dyspeptic
Symptoms at a Referral Center in Medellin.” Revista Colombiana de Gastroenterologia
31 (1): 9–15. www.scielo.org.co/pdf/rcg/v31n1/en_v31n1a02.pdf.
Crabtree,  J  E,  S M Farmery,  I  J  Lindley,  N Figura,  P Peichl,  and D S Tompkins.  1994.
“CagA/cytotoxic Strains of  Helicobacter pylori and Interleukin-8 in Gastric Epithelial
Cell Lines.” J Clin Pathol 47 (10): 945–50.
Engstrand,  L.  2001.  “Helicobacter in  Water  and  Waterborne  Routes  of  Transmission.”
Symp.Ser.Soc Appl.Microbiol., no. 30: 80S–84S.
Falush, D, T Wirth, B Linz, J K Pritchard, M Stephens, M Kidd, M J Blaser, et al. 2003.
“Traces of Human Migrations in Helicobacter pylori Populations.” Science. 299 (5612):
1582–85.
Fassan, M, M Rugge, P Parente, C Tieppo, M Rugge, and G Battaglia. 2009. “The Role of
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 25 of 34
Accumulative Professorial Dissertation
Helicobacter  pylori in  the  Spectrum of  Barrett’s  Carcinogenesis.”  Cancer  Prev  Res
(Phila) 2 (1): 94. doi:10.1158/1940-6207.capr-08-0194.
Figura, N, C Vindigni, A Covacci, L Presenti, D Burroni, R Vernillo, T Banducci, et al. 1998.
“cagA Positive and Negative Helicobacter pylori Strains Are Simultaneously Present in
the  Stomach  of  Most  Patients  with  Non-Ulcer  Dyspepsia:  Relevance  to  Histological
Damage.” Gut 42 (6): 772–78. http://www.ncbi.nlm.nih.gov/pubmed/9691913.
Fischer,  W,  J  Puls,  R Buhrdorf,  B Gebert,  S  Odenbreit,  and  R Haas.  2001.  “Systematic
Mutagenesis of the  Helicobacter pylori Cag Pathogenicity Island: Essential Genes for
CagA Translocation in Host Cells and Induction of Interleukin-8.”  Mol.Microbiol. 42
(5): 1337–48.
Fischer,  Wolfgang,  Renate  Buhrdorf,  Elke  Gerland,  and  Rainer  Haas.  2001.  “Outer
Membrane  Targeting  of  Passenger  Proteins  by  the  Vacuolating  Cytotoxin
Autotransporter of  Helicobacter pylori.” Edited by D L Burns.  Infection and Immunity
69  (11).  American  Society  for  Microbiology:  6769–75.  doi:10.1128/IAI.69.11.6769-
6775.2001.
Fu, Hualin, Yue Ma, Meng Yang, Chunlei Zhang, Hai Huang, Ying Xia, Lungen Lu, Weilin
Jin, and Daxiang Cui. 2016. “Persisting and Increasing Neutrophil Infiltration Associates
with Gastric Carcinogenesis and E-Cadherin Downregulation” 6 (July). The Author(s):
29762. http://dx.doi.org/10.1038/srep29762.
Gavalas,  E,  J  Kountouras,  M Boziki,  C Zavos,  S A Polyzos,  E Vlachaki,  I  Venizelos,  D
Tsiptsios, and G Deretzi. 2015. “Relationship between Helicobacter pylori Infection and
Multiple Sclerosis.” Ann Gastroenterol 28 (3): 353–56.
Gebert,  B,  W  Fischer,  E  Weiss,  R  Hoffmann,  and  R  Haas.  2003.  “Helicobacter  pylori
Vacuolating Cytotoxin Inhibits T Lymphocyte Activation.”  Science 301 (5636): 1099–
1102.
Goodman, K J, P Correa, H J Tengana Aux, H Ramirez, J P DeLany, O Guerrero Pepinosa, M
Lopez  Quinones,  and  T  Collazos  Parra.  1996.  “Helicobacter  pylori Infection  in  the
Colombian  Andes:  A  Population-Based  Study  of  Transmission  Pathways.”  Am  J
Epidemiol 144 (3): 290–99.
Gurtler, A, N Kunz, M Gomolka, S Hornhardt, A A Friedl, K McDonald, J E Kohn, and A
Posch.  2013.  “Stain-Free  Technology  as  a  Normalization  Tool  in  Western  Blot
Analysis.” Anal Biochem 433 (2): 105–11. doi:10.1016/j.ab.2012.10.010.
Halme, L, H Rautelin, M Leidenius, and T U Kosunen. 1996. “Inverse Correlation between
Helicobacter pylori Infection and Inflammatory Bowel Disease.”  J Clin Pathol 49 (1):
65–67.
Islami, Farhad, and Farin Kamangar. 2008. “&lt;em&gt;Helicobacter pylori&lt;/em&gt; and
Esophageal Cancer Risk: A Meta-Analysis.” Cancer Prevention Research 1 (5): 329 LP-
338. http://cancerpreventionresearch.aacrjournals.org/content/1/5/329.abstract.
Javaheri, Anahita, Tobias Kruse, Kristof Moonens, Raquel Mejías-Luque, Ayla Debraekeleer,
Carmen I Asche, Nicole Tegtmeyer,  et al.  2016. “Helicobacter pylori Adhesin HopQ
Engages in a Virulence-Enhancing Interaction with Human CEACAMs” 2 (October).
Macmillan Publishers Limited: 16189. http://dx.doi.org/10.1038/nmicrobiol.2016.189.
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 26 of 34
Accumulative Professorial Dissertation
Jimenez-Soto, L F, S Clausen, A Sprenger, C Ertl, and R Haas. 2013. “Dynamics of the Cag-
Type IV Secretion System of Helicobacter pylori as Studied by Bacterial Co-Infections.”
Cell Microbiol 15 (11): 1924–37. doi:10.1111/cmi.12166.
Jimenez-Soto, L F, and R Haas. 2016. “The CagA Toxin of  Helicobacter pylori: Abundant
Production  but  Relatively  Low  Amount  Translocated.”  Sci  Rep 6:  23227.
doi:10.1038/srep23227.
Jimenez-Soto, L F, S Kutter, X Sewald, C Ertl,  E Weiss, U Kapp, M Rohde, et al.  2009.
“Helicobacter pylori Type IV Secretion Apparatus Exploits beta1 Integrin in a Novel
RGD-Independent  Manner.”  PLoS  Pathog 5  (12):  e1000684.
doi:10.1371/journal.ppat.1000684.
Jimenez-Soto,  L  F,  S Rohrer,  U Jain,  C Ertl,  X Sewald,  and  R Haas.  2012.  “Effects  of
Cholesterol  on  Helicobacter  pylori Growth  and  Virulence  Properties  in  Vitro.”
Helicobacter 17 (2): 133–39. doi:10.1111/j.1523-5378.2011.00926.x.
Jungblut,  P  R,  D  Bumann,  G  Haas,  U  Zimny-Arndt,  P  Holland,  S  Lamer,  F  Siejak,  A
Aebischer,  and T F  Meyer.  2000.  “Comparative  Proteome Analysis  of  Helicobacter
pylori.” Mol Microbiol 36 (3): 710–25. http://www.ncbi.nlm.nih.gov/pubmed/10844659.
Kaplan-Turkoz, B, L F Jimenez-Soto, C Dian, C Ertl, H Remaut, A Louche, T Tosi, R Haas,
and L Terradot. 2012. “Structural Insights into  Helicobacter pylori Oncoprotein CagA
Interaction  with  beta1  Integrin.”  Proc  Natl  Acad  Sci  U  S  A 109  (36):  14640–45.
doi:10.1073/pnas.12060981091206098109 [pii].
Königer, Verena, Lea Holsten, Ute Harrison, Benjamin Busch, Eva Loell, Qing Zhao, Daniel
A. Bonsor, et al. 2016. “Helicobacter pylori Exploits Human CEACAMs via HopQ for
Adherence and Translocation of CagA.”  Nature Microbiology 2 (October). Macmillan
Publishers Limited: 16188. doi:10.1038/nmicrobiol.2016.188.
Kudo, M, O Gutierrez, H M El-Zimaity, H Cardona, Z Z Nurgalieva, J Wu, and D Y Graham.
2005. “CagA in Barrett’s Oesophagus in Colombia, a Country with a High Prevalence of
Gastric Cancer.” J Clin Pathol 58 (3): 259–62. doi:10.1136/jcp.2004.022251.
Li,  W,  M  Minohara,  J  J  Su,  T  Matsuoka,  M  Osoegawa,  T  Ishizu,  and  J  Kira.  2007.
“Helicobacter  pylori Infection  Is  a  Potential  Protective  Factor  against  Conventional
Multiple  Sclerosis  in  the  Japanese Population.”  J  Neuroimmunol 184 (1–2):  227–31.
doi:10.1016/j.jneuroim.2006.12.010.
Linz, B, F Balloux, Y Moodley, A Manica, H Liu, P Roumagnac, D Falush, et al. 2007. “An
African Origin for the Intimate Association between Humans and Helicobacter pylori.”
Nature. 445 (7130): 915–18.
Linz, B, H M Windsor, J P Gajewski, C M Hake, D I Drautz, S C Schuster, and B J Marshall.
2013.  “Helicobacter  pylori Genomic  Microevolution  during  Naturally  Occurring
Transmission  between  Adults.”  PLoS  One 8  (12):  e82187.
doi:10.1371/journal.pone.0082187.
Marshall,  B J, J A Armstrong, D B McGechie,  and R J Glancy. 1985. “Attempt to Fulfil
Koch’s Postulates for Pyloric Campylobacter.” Med.J.Aust. 142 (8): 436–39.
Marshall, B J, and J R Warren. 1984. “Unidentified Curved Bacilli in the Stomach of Patients
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 27 of 34
Accumulative Professorial Dissertation
with Gastritis and Peptic Ulceration.” Lancet 1 (8390): 1311–15.
Mueller, D, N Tegtmeyer, S Brandt, Y Yamaoka, E De Poire, D Sgouras, S Wessler, J Torres,
A  Smolka,  and  S  Backert.  2012.  “C-Src  and  c-Abl  Kinases  Control  Hierarchic
Phosphorylation and Function of the CagA Effector Protein in Western and East Asian
Helicobacter pylori Strains.” J Clin Invest 122 (4): 1553–66. doi:10.1172/JCI61143.
Odenbreit, S, B Gebert, J Puls, W Fischer, and R Haas. 2001.  “Interaction of  Helicobacter
pylori with  Professional  Phagocytes:  Role  of  the  Cag  Pathogenicity  Island  and
Translocation, Phosphorylation and Processing of CagA.” Cell Microbiol 3 (1): 21–31.
Odenbreit, S, J Puls, B Sedlmaier, E Gerland, W Fischer, and R Haas. 2000. “Translocation of
Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion.”  Science
287 (5457): 1497–1500.
Oertli, M, M Noben, D B Engler, R P Semper, S Reuter, J Maxeiner, M Gerhard, C Taube,
and  A  Muller.  2013.  “Helicobacter  pylori Gamma-Glutamyl  Transpeptidase  and
Vacuolating Cytotoxin Promote Gastric Persistence and Immune Tolerance.” Proc Natl
Acad Sci U S A 110 (8): 3047–52. doi:10.1073/pnas.1211248110.
Owen, R J. 1998. “Helicobacter--Species Classification and Identification.” Br.Med Bull. 54
(1): 17–30.
Pham, K T, E Weiss, L F Jimenez Soto, U Breithaupt, R Haas, and W Fischer. 2012. “CagI Is
an Essential Component of the Helicobacter pylori Cag Type IV Secretion System and
Forms  a  Complex  with  CagL.”  PLoS  One 7  (4):  e35341.
doi:10.1371/journal.pone.0035341PONE-D-11-14342 [pii].
Poppe, M, S M Feller,  G Romer, and S Wessler. 2007. “Phosphorylation of  Helicobacter
pylori CagA by c-Abl Leads to Cell Motility.” Oncogene 26 (24): 3462–72. doi:10.1038/
sj.onc.1210139.
Reibman,  Joan,  Michael  Marmor,  Joshua  Filner,  Maria-Elena  Fernandez-Beros,  Linda
Rogers,  Guillermo  I  Perez-Perez,  and  Martin  J  Blaser.  2008.  “Asthma  Is  Inversely
Associated with Helicobacter pylori Status in an Urban Population.” Edited by Dominik
Hartl.  PLoS  ONE 3  (12).  San  Francisco,  USA:  Public  Library  of  Science:  e4060.
doi:10.1371/journal.pone.0004060.
Rhee, Sang H, Charalabos Pothoulakis, and Emeran A Mayer. 2009. “Principles and Clinical
Implications  of  the  Brain–gut–enteric  Microbiota  Axis.”  Nature  Reviews.
Gastroenterology  &  Hepatology 6  (5):  10.1038/nrgastro.2009.35.
doi:10.1038/nrgastro.2009.35.
Rojas-Rengifo,  D F, C A Jaramillo,  R Haas,  and L F Jimenez-Soto.  2015.  “Detection  of
Cytoplasmic  Proteins  from  Helicobacter  pylori in  Colony  Lift  Immunoassay.”  J
Microbiol Methods 119: 145–46. doi:10.1016/j.mimet.2015.10.005.
Schindele, Franziska, Evelyn Weiss, Rainer Haas, and Wolfgang Fischer. 2016. “Quantitative
Analysis  of  CagA  Type  IV  Secretion  by  Helicobacter  pylori Reveals  Substrate
Recognition and Translocation Requirements.”  Molecular Microbiology 100 (1): 188–
203. doi:10.1111/mmi.13309.
Secka, O, M Antonio, D E Berg, M Tapgun, C Bottomley, V Thomas, R Walton, T Corrah, J
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 28 of 34
Accumulative Professorial Dissertation
E Thomas, and R A Adegbola. 2011. “Mixed Infection with cagA Positive and cagA
Negative Strains of Helicobacter pylori Lowers Disease Burden in The Gambia.” PLoS
One 6 (11): e27954. doi:10.1371/journal.pone.0027954PONE-D-11-13954 [pii].
Sewald, X, B Gebert-Vogl, S Prassl, I Barwig, E Weiss, M Fabbri, R Osicka, et al. 2008.
“Integrin  Subunit  CD18  Is  the  T-Lymphocyte  Receptor  for  the  Helicobacter  pylori
Vacuolating Cytotoxin.” Cell Host.Microbe 3 (1): 20–29.
Sewald,  X,  L  Jimenez-Soto,  and  R  Haas.  2011.  “PKC-Dependent  Endocytosis  of  the
Helicobacter pylori Vacuolating Cytotoxin in Primary T Lymphocytes.” Cell Microbiol
13 (3): 482–96. doi:10.1111/j.1462-5822.2010.01551.x.
Singer,  M,  and  P  J  Sansonetti.  2004.  “IL-8  Is  a  Key  Chemokine  Regulating  Neutrophil
Recruitment in a New Mouse Model of Shigella-Induced Colitis.”  J.Immunol. 173 (6):
4197–4206.
Sokolova, O, M Borgmann, C Rieke, K Schweitzer, H J Rothkotter, and M Naumann. 2013.
“Helicobacter  pylori Induces  Type  4  Secretion  System-Dependent,  but  CagA-
Independent Activation of IkappaBs and NF-kappaB/RelA at Early Time Points.” Int J
Med Microbiol 303 (8): 548–52. doi:10.1016/j.ijmm.2013.07.008.
Stein, M, R Rappuoli, and A Covacci. 2000. “Tyrosine Phosphorylation of the Helicobacter
pylori CagA Antigen after Cag-Driven Host Cell Translocation.” Proc Natl Acad Sci U S
A 97 (3): 1263–68.
Tan, S, J M Noto, J Romero-Gallo, R M Peek Jr., and M R Amieva. 2011. “Helicobacter
pylori Perturbs Iron Trafficking in the Epithelium to Grow on the Cell Surface.”  PLoS
Pathog 7 (5): e1002050. doi:10.1371/journal.ppat.1002050.
Torres,  Javier,  Pelayo  Correa,  Catterina  Ferreccio,  Gustavo  Hernandez-Suarez,  Rolando
Herrero,  Maria  Cavazza-Porro,  Ricardo  Dominguez,  and  Douglas  Morgan.  2013.
“Gastric Cancer Incidence and Mortality Is Associated with Altitude in the Mountainous
Regions of Pacific Latin America.”  Cancer Causes & Control : CCC 24 (2): 249–56.
doi:10.1007/s10552-012-0114-8.
Vaezi, M F, G W Falk, R M Peek, J J Vicari, J R Goldblum, G I Perez-Perez, T W Rice, M J
Blaser,  and  J  E  Richter.  2000.  “CagA-Positive  Strains  of  Helicobacter  pylori May
Protect  against  Barrett’s  Esophagus.”  Am  J  Gastroenterol 95  (9):  2206–11.
doi:10.1111/j.1572-0241.2000.02305.x.
Vaira, D, J Holton, M Menegatti, L Gatta, C Ricci, A Ali, F Landi, C Moretti, and M Miglioli.
1998. “Routes of Transmission of  Helicobacter pylori Infection.”  Ital J Gastroenterol
Hepatol 30 Suppl 3: S279-85.
Warburton, V J, S Everett,  N P Mapstone, A T Axon, P Hawkey, and M F Dixon. 1998.
“Clinical and Histological Associations of cagA and vacA Genotypes in  Helicobacter
pylori Gastritis.”  J  Clin  Pathol 51  (1):  55–61.
http://www.ncbi.nlm.nih.gov/pubmed/9577374.
Wunder,  Christian,  Yuri  Churin,  Florian  Winau,  Dirk  Warnecke,  Michael  Vieth,  Buko
Lindner,  Ulrich  Zahringer,  Hans-Joachim  Mollenkopf,  Ernst  Heinz,  and  Thomas  F
Meyer. 2006. “Cholesterol  Glucosylation Promotes Immune Evasion by  Helicobacter
pylori.” Nature Medicine 12 (9). United States: 1030–38. doi:10.1038/nm1480.
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 29 of 34
Accumulative Professorial Dissertation
Xiang, Z, S Censini, P F Bayeli, J L Telford, N Figura, R Rappuoli, and A Covacci. 1995.
“Analysis  of  Expression  of  CagA  and  VacA  Virulence  Factors  in  43  Strains  of
Helicobacter  pylori Reveals  That  Clinical  Isolates  Can  Be Divided into  Two Major
Types and That CagA Is Not Necessary for Expression of the Vacuolating Cytotoxin.”
Infect Immun 63 (1): 94–98. http://www.ncbi.nlm.nih.gov/pubmed/7806390.
Zeitler, A F, K H Gerrer, R Haas, and L F Soto. 2016. “Optimized Semi-Quantitative Blot
Analysis in Infection Assays Using the Stain-Free Technology.”  J Microbiol Methods.
doi:10.1016/j.mimet.2016.04.016.
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 30 of 34
Accumulative Professorial Dissertation
Publications
4 Peer reviewed
Zeitler, A. F., Gerrer, K. H., Haas, R. & Jimenez-Soto, L. F. Host cell resistance to CagA
translocation  is  as  variable  as  Helicobacter  pylori.  Matters.  Oct  23rd,  2017.  DOI:
10.19185/matters.201706000006.
Koelblen T, Bergé C, Cherrier MV, Brillet K, Jimenez-Soto L, Ballut L, Takagi J, Montserret
R, Rousselle P, Fischer W, Haas R, Fronzes R, Terradot L. Molecular dissection of protein-
protein interactions between integrin α5β1 and the Helicobacter pylori Cag Type IV secretion
system. FEBS J. 2017 Oct 21. doi:10.1111/febs.14299.
Zeitler, A. F., Gerrer, K. H., Haas, R. & Jimenez-Soto, L. F. Optimized semi-quantitative
blot  analysis  in  infection  assays  using  the  stain-free  technology.  J  Microbiol  Methods,
doi:10.1016/j.mimet.2016.04.016 (2016).
Jimenez-Soto, L. F. & Haas, R. The CagA toxin of Helicobacter pylori: abundant production
but relatively low amount translocated. Sci Rep 6, 23227, doi:10.1038/srep23227 (2016).
Rojas-Rengifo  DF,  Jaramillo  CA,  Haas  R,  Jiménez-Soto  LF.  Detection  of  cytoplasmic
proteins from Helicobacter pylori in Colony Lift Immunoassay. J Microbiol Methods. 2015
Dec;119:145-6.  doi:  10.1016/j.mimet.2015.10.005.  Epub  2015  Oct  9.  PubMed  PMID:
26456045.
Kern  B,  Jain  U,  Utsch  C,  Otto  A,  Busch B,  Jimenez-Soto  L,  et  al.  Characterization  of
Helicobacter  pylori VacA-containing  vacuoles  (VCVs),  VacA intracellular  trafficking and
interference with calcium signalling in T lymphocytes. Cell Microbiol. 2015.
Keller B, Muhlenkamp M, Deuschle E, Siegfried A, Mossner S, Schade J, et  al.  Yersinia
enterocolitica exploits different pathways to accomplish adhesion and toxin injection into host
cells. Cell Microbiol. 2015
Jimenez-Soto,  L.  F.,  S.  Clausen,  et  al.  (2013).  "Dynamics  of  the  Cag-type  IV secretion
system of  Helicobacter  pylori as studied by bacterial  co-infections."  Cell Microbiol.  July
2013
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 31 of 34
Accumulative Professorial Dissertation
Kaplan-Türköz B*, Jiménez-Soto LF*, Dian C, Ertl C, Remaut H, Louche A, Tosi T, Haas
R, Terradot L. Structural insights into Helicobacter pylori oncoprotein CagA interaction with
β1 integrin. Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14640-5
Pham KT, Weiss E, Jiménez-Soto LF, Breithaupt U, Haas R, Fischer W. CagI is an essential
component of the  Helicobacter pylori Cag type IV secretion system and forms a complex
with CagL. PLoS One. 2012;7(4):e35341.
Jiménez-Soto LF, Rohrer S, Jain, U, Ertl C, Sewald X, Haas, R. Effects of cholesterol on
Helicobacter  pylori growth  and  virulence  properties  in  vitro.  Helicobacter.  2012
Apr;17(2):133-9.
Nägele V, Heesemann J, Schielke S,  Jiménez-Soto LF, Kurzai O, Ackermann N. Neisseria
meningitidis  Adhesin  NadA  Targets  beta  1  Integrins:  Functional  similarity  to  Yersinia
Invasin. J Biol Chem. 2011 Jun 10;286(23):20536-46. Epub 2011 Apr 6.
Sewald X, Jiménez-Soto L, Haas R. PKC-dependent endocytosis of the Helicobacter pylori
vacuolating cytotoxin in primary T lymphocytes. Cell Microbiol. 2011 Mar;13(3):482-96
Jiménez-Soto LF,  Kutter S, Sewald X, Ertl C, Weiss E, et al.  (2009)  Helicobacter pylori
Type IV Secretion Apparatus  Exploits  β1 Integrin  in  a Novel  RGD-Independent  Manner.
PLoS Pathog 5(12)
Fischer W, Karnholz A,  Jimenez-Soto LF, and Haas, R. (2008) Type IV secretion systems in
Helicobacter  pylori. In:  Helicobacter  pylori:  Molecular  Genetics  and  Cellular  Biology;
Y.Yamaoka, Ed., Caister Academic Press, Norfolk, UK; p. 115-136
Sherer  NM, Lehmann MJ, Jimenez-Soto LF,  Horensavitz  C, Pypaert  M, and Mothes W.
(2007).  Retroviruses  can establish  filopodial  bridges for efficient  cell-to-cell  transmission.
Nat. Cell Biol. 9, 310-315.
Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, Cicchetti G, Allen
PG,  Pypaert  M,  Cunningham  JM,  and  Mothes  W.  (2003).  Visualization  of  retroviral
replication in living cells reveals budding into multivesicular bodies. Traffic. 4, 785-80
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 32 of 34
Accumulative Professorial Dissertation
5 Other publications
 Wolfgang Fischer, Arno Karnholz, Luisa F. Jimenez-Soto and Rainer Haas. Type IV 
Secretion Systems, from: Helicobacter pylori: Molecular Genetics and Cellular 
Biology (Edited by: Yoshio Yamaoka). Caister Academic Press, U.K. (2008)
 A misunderstood microbe: new approaches to Helicobacter pylori co-infection March 
2008 
https://www.researchgate.net/publication/297403488_A_misunderstood_microbe_new
_approaches_to_Helicobacter_pylori_co-infection 
 Trans-blot® Turbo™ transfer with home-made buffers. 
Protocols.io.dx.doi.org/10.17504/protocols.io.ghhbt36
 Semi-quantitative analysis of western blot signals. Protocols.io. Jun 08, 2017. DOI: 
dx.doi.org/10.17504/protocols.io.hjzb4p6
 Shipment of H. pylori samples. Protocols.io. Jun 08, 2017. DOI: dx.doi.org/10.17504/
protocols.io.h85b9y6
 Sandwich ELISA for IL-8 detection in supernatants. Protocols.io. Jun 08, 2017. DOI: 
dx.doi.org/10.17504/protocols.io.gz7bx9n
 Pre-infection experiments for CagA translocation. Protocols.io. Jun 08, 2017. DOI: 
dx.doi.org/10.17504/protocols.io.gz5bx86
 Isolation of leucocytes from human blood. Protocols.io. Jun 08, 2017. DOI: 
dx.doi.org/10.17504/protocols.io.hjxb4pn
 Co-infection experiments for CagA translocation. Protocols.io. Jun 08, 2017. DOI: 
dx.doi.org/10.17504/protocols.io.hjpb4mn
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 33 of 34
Accumulative Professorial Dissertation
Eidesstattliche Versicherung
Ich, Dr. Luisa Fernanda Jiménez Soto, erkläre hiermit an Eides statt,
dass ich die vorliegende Habilitationsarbeit mit dem Thema
Molecular studies on Helicobacter pylori and the conditions for its toxicity
selbständig  verfasst,  mich außer der  angegebenen keiner  weiteren Hilfsmittel
bedient  und  alle  Erkenntnisse,  die  aus  dem Schrifttum ganz oder  annähernd
übernommen sind, als solche kenntlich gemacht und nach ihrer Herkunft unter
Bezeichnung der Fundstelle einzeln nachgewiesen habe.
Ich  erkläre  des  Weiteren,  dass  die  hier  vorgelegte  schriftliche
Habilitationsleistung nicht in gleicher oder in ähnlicher Form bei einer anderen
Stelle eingereicht wurde.
München, 6.November, 2017 ___________________________
        Dr. Luisa F. Jiménez Soto
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
Page 34 of 34
Accumulative Professorial Dissertation
Erklärung 
Ich, Dr. Luisa Fernanda Jimenez Soto, erkläre hiermit, dass 
 ich nicht schon zweimal ein Habilitationsverfahren im gleichen Fach ohne
Erfolg beendet habe, und
 mir kein akademischer Grad entzogen worden ist und auch kein Verfahren
gegen mich anhängig ist, das die Entziehung eines akademischen Grades
zur Folge haben könnte. 
München, 6.November, 2017 ___________________________
        Dr. Luisa F. Jiménez Soto
Dr.  Luisa  Fernanda  Jiménez  Soto,  Max  von  Pettenkofer-Institute  for  Medical  Microbiology  and  Hospital
Epidemiology, Medical Faculty – LMU Munich
